Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Provided By PR Newswire
Last update: Feb 25, 2025
BOULDER, Colo., Feb. 25, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025, at 10:30 a.m. ET.
Read more at prnewswire.com
